Skip to main content

Table 2 Summary of results of treatment options with regard to implantation rate, clinical pregnancy rate, and live birth rate

From: RecurrentĀ ImplantationĀ Failure-update overview on etiology, diagnosis, treatment and future directions

Ā 

Implantation Rate

Clinical Pregnancy Rate

Live Birth Outcome

Source

(treatment vs. control)

(treatment vs. control)

(treatment vs. control)

Tacrolimus

45.7% vs. 0%

64% vs. 0%

60% vs. 0%

Nakagawa et al., 2015 [36]

(Pā€‰<ā€‰0.0001)

(Pā€‰<ā€‰0.0001)

(Pā€‰<ā€‰0.0001)

IVIG

34.4% vs. 13.7%

60.2% vs. 39.3%

49.8% vs. 31.6%

Li et al., 2013 [82] (meta-analysis)

RR 2.708

RR 1.475

RR 1.616

(95% CI: 1.302ā€“5.629, I2ā€‰=ā€‰65.0%)

(95% CI: 1.191ā€“1.825, I2ā€‰=ā€‰65.7%)

(95% CI: 1.243ā€“2.101, I2ā€‰=ā€‰58.2%)

PBMC

22% vs. 4.88%

39.58% vs. 14.29%

33.33% vs.9.58%

Li et al., 2017 [84]

(Pā€‰=ā€‰0.014)

(Pā€‰=ā€‰0.038)

(Pā€‰=ā€‰0.038)

G-CSF

31.5% vs. 13.9%

48.1% vs. 25%

33.3% vs. 17.3%

Xu et al., 2015 [87]

(Pā€‰<ā€‰0.01)

(Pā€‰<ā€‰0.01)

NS

Antibiotics for CE

37% vs. 17%

65.2% vs. 33%

60.8% vs. 13.3%

Cicinelli et al., 2015 [44]

NS

(Pā€‰=ā€‰0.039)

(Pā€‰=ā€‰0.02)

Salpingectomy

25.6% vs. 12.3%

45.7% vs. 22.5%

40% vs. 17.5%

Strandell et al., 1999 [94]

(Pā€‰=ā€‰0.038)

(Pā€‰=ā€‰0.029)

(Pā€‰=ā€‰0.038)

Endometrial Biopsy

27.7%, vs. 14.2%

66.7% vs. 30.3%

48.9% vs. 22.5%

Barash et al., 2003 [96]

(Pā€‰=ā€‰.00011)

(Pā€‰=ā€‰.00009)

(Pā€‰=ā€‰.016)

IMSI procedure

19.2% vs. 7.8%

43.1% vs. 10.5%

34.7% vs. 0%

Shalom-Paz et al., 2015 [109]

(Pā€‰=ā€‰0.042)

(Pā€‰=ā€‰0.02)

(Pā€‰=ā€‰0.003)